Rational design of inducible CRISPR guide RNAs for de novo assembly of transcriptional programs

• Published in: Nature communications Vol. 8; no. 1; pp. 14633 - 10
• Main Authors: Ferry, Quentin R. V., Lyutova, Radostina, Fulga, Tudor A.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 03.03.2017; Nature Publishing Group; Nature Portfolio
• Subjects: 631/1647/1511; 631/208/4041/3196; 631/92/552; Algorithms; Clustered Regularly Interspaced Short Palindromic Repeats - genetics; CRISPR; Design; Flow Cytometry; Gene Regulatory Networks - genetics; Genes; Genetic Engineering - methods; Genetic Vectors - genetics; HEK293 Cells; Humanities and Social Sciences; Humans; Ligands; multidisciplinary; Proteins; RNA, Guide, CRISPR-Cas Systems - genetics; Science; Science (multidisciplinary); Synthetic biology; Transcriptional Activation - genetics; Transfection
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/ncomms14633

CRISPR-based transcription regulators (CRISPR-TRs) have transformed the current synthetic biology landscape by allowing specific activation or repression of any target gene. Here we report a modular and versatile framework enabling rapid implementation of inducible CRISPR-TRs in mammalian cells. This strategy relies on the design of a spacer-blocking hairpin (SBH) structure at the 5′ end of the single guide RNA (sgRNA), which abrogates the function of CRISPR-transcriptional activators. By replacing the SBH loop with ligand-controlled RNA-cleaving units, we demonstrate conditional activation of quiescent sgRNAs programmed to respond to genetically encoded or externally delivered triggers. We use this system to couple multiple synthetic and endogenous target genes with specific inducers, and assemble gene regulatory modules demonstrating parallel and orthogonal transcriptional programs. We anticipate that this ‘plug and play’ approach will be a valuable addition to the synthetic biology toolkit, facilitating the understanding of natural gene circuits and the design of cell-based therapeutic strategies. Being able to regulate gene expression in a controllable manner is one of the promises of synthetic biology, and CRISPR-Cas9 is one of the tools being developed to achieve that goal. Here the authors develop an inducible CRISPR platform using an engineered guide RNA.